Details for Patent: 9,101,592

Which drugs does patent 9,101,592 protect, and when does it expire?

Patent 9,101,592 protects GONITRO and is included in one NDA.

This patent has thirteen patent family members in six countries.

Summary for Patent: 9,101,592

Patent landscape, scope, and claims:

Title:	Stabilized granules containing glyceryl trinitrate
Abstract:	Solid pharmaceutical preparation with the active substance glyceryl trinitrate for oromucosal or oral administration characterized in that it contains between 0.05 and 2 weight % glyceryl trinitrate, at least one carrier material, and at least one substance that reduces the volatility of the GTN, whereby this substance is a non-volatile ester stabilizer.
Inventor(s):	Zimmeck; Thomas (Hohenlockstedt, DE), Ueck; Henning (Bekmunde, DE), Gehricke; Julia (Kiel, DE)
Assignee:	G. POHL-BOSKAMP GMBH & CO. KG (Hohenlockstedt, DE)
Application Number:	14/473,415
Patent Claim Types: see list of patent claims	Composition; Compound; Formulation; Use; Dosage form;

Drugs Protected by US Patent 9,101,592

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Pohl Boskamp	GONITRO	nitroglycerin	POWDER;SUBLINGUAL	208424-001	Jun 8, 2016		DISCN	Yes	No			Y

Foreign Priority and PCT Information for Patent: 9,101,592

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	10 2011 012 491	Feb 25, 2011

International Family Members for US Patent 9,101,592

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2012219925
Australia	2012219926
Canada	2827714
Canada	2827716
European Patent Office	2678000
European Patent Office	2678006
European Patent Office	3354259